Nicotine as a Conditioned Stimulus: Impact of Attention-Deficit/Hyperactivity Disorder Medications

Carmela M. Reichel, Jessica D. Linkugel, Rick A Bevins

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

People diagnosed with attention-deficit/hyperactivity disorder (ADHD) are at an increased risk to start smoking and have greater difficulty quitting. Nicotine, one of the principal addictive components of tobacco smoke, functioned as a conditioned stimulus (CS) for intermittent sucrose delivery in a Pavlovian drug discrimination task with rats. This study compared the ability of commonly prescribed ADHD medications (i.e., methylphenidate, atomoxetine, and bupropion) and additional dopamine reuptake inhibitors (i.e., cocaine and GBR 12909) to substitute for the CS effects of nicotine. Atomoxetine was also used to antagonize these CS effects. Rats acquired the discrimination as evidenced by increased dipper entries in nicotine (0.2 mg base/kg) sessions as compared with saline sessions. Nicotine generalization was dose dependent. Bupropion (10 and 20 mg/kg), methylphenidate (10 mg/kg), and cocaine (5 and 10 mg/kg) partially substituted for the 0.2 mg/kg nicotine CS. Atomoxetine did not substitute for the nicotine CS; however, atomoxetine (1 to 10 mg/kg) partially blocked nicotine's CS effects. These results suggest that atomoxetine, bupropion, and/or methylphenidate may be effective treatments for people diagnosed with ADHD and addicted to nicotine.

Original languageEnglish (US)
Pages (from-to)501-509
Number of pages9
JournalExperimental and Clinical Psychopharmacology
Volume15
Issue number5
DOIs
StatePublished - Oct 1 2007

Fingerprint

Attention Deficit Disorder with Hyperactivity
Nicotine
Methylphenidate
Bupropion
Cocaine
Dopamine Uptake Inhibitors
Aptitude
Smoke
Tobacco
Sucrose
Smoking
Atomoxetine Hydrochloride
Pharmaceutical Preparations

Keywords

  • dopamine
  • drug discrimination
  • interoceptive Pavlovian conditioning
  • nicotinic acetylcholine receptors
  • norepinephrine

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Nicotine as a Conditioned Stimulus : Impact of Attention-Deficit/Hyperactivity Disorder Medications. / Reichel, Carmela M.; Linkugel, Jessica D.; Bevins, Rick A.

In: Experimental and Clinical Psychopharmacology, Vol. 15, No. 5, 01.10.2007, p. 501-509.

Research output: Contribution to journalArticle

@article{85eedcf80e3543ebbe67244f1498993f,
title = "Nicotine as a Conditioned Stimulus: Impact of Attention-Deficit/Hyperactivity Disorder Medications",
abstract = "People diagnosed with attention-deficit/hyperactivity disorder (ADHD) are at an increased risk to start smoking and have greater difficulty quitting. Nicotine, one of the principal addictive components of tobacco smoke, functioned as a conditioned stimulus (CS) for intermittent sucrose delivery in a Pavlovian drug discrimination task with rats. This study compared the ability of commonly prescribed ADHD medications (i.e., methylphenidate, atomoxetine, and bupropion) and additional dopamine reuptake inhibitors (i.e., cocaine and GBR 12909) to substitute for the CS effects of nicotine. Atomoxetine was also used to antagonize these CS effects. Rats acquired the discrimination as evidenced by increased dipper entries in nicotine (0.2 mg base/kg) sessions as compared with saline sessions. Nicotine generalization was dose dependent. Bupropion (10 and 20 mg/kg), methylphenidate (10 mg/kg), and cocaine (5 and 10 mg/kg) partially substituted for the 0.2 mg/kg nicotine CS. Atomoxetine did not substitute for the nicotine CS; however, atomoxetine (1 to 10 mg/kg) partially blocked nicotine's CS effects. These results suggest that atomoxetine, bupropion, and/or methylphenidate may be effective treatments for people diagnosed with ADHD and addicted to nicotine.",
keywords = "dopamine, drug discrimination, interoceptive Pavlovian conditioning, nicotinic acetylcholine receptors, norepinephrine",
author = "Reichel, {Carmela M.} and Linkugel, {Jessica D.} and Bevins, {Rick A}",
year = "2007",
month = "10",
day = "1",
doi = "10.1037/1064-1297.15.5.501",
language = "English (US)",
volume = "15",
pages = "501--509",
journal = "Experimental and Clinical Psychopharmacology",
issn = "1064-1297",
publisher = "American Psychological Association Inc.",
number = "5",

}

TY - JOUR

T1 - Nicotine as a Conditioned Stimulus

T2 - Impact of Attention-Deficit/Hyperactivity Disorder Medications

AU - Reichel, Carmela M.

AU - Linkugel, Jessica D.

AU - Bevins, Rick A

PY - 2007/10/1

Y1 - 2007/10/1

N2 - People diagnosed with attention-deficit/hyperactivity disorder (ADHD) are at an increased risk to start smoking and have greater difficulty quitting. Nicotine, one of the principal addictive components of tobacco smoke, functioned as a conditioned stimulus (CS) for intermittent sucrose delivery in a Pavlovian drug discrimination task with rats. This study compared the ability of commonly prescribed ADHD medications (i.e., methylphenidate, atomoxetine, and bupropion) and additional dopamine reuptake inhibitors (i.e., cocaine and GBR 12909) to substitute for the CS effects of nicotine. Atomoxetine was also used to antagonize these CS effects. Rats acquired the discrimination as evidenced by increased dipper entries in nicotine (0.2 mg base/kg) sessions as compared with saline sessions. Nicotine generalization was dose dependent. Bupropion (10 and 20 mg/kg), methylphenidate (10 mg/kg), and cocaine (5 and 10 mg/kg) partially substituted for the 0.2 mg/kg nicotine CS. Atomoxetine did not substitute for the nicotine CS; however, atomoxetine (1 to 10 mg/kg) partially blocked nicotine's CS effects. These results suggest that atomoxetine, bupropion, and/or methylphenidate may be effective treatments for people diagnosed with ADHD and addicted to nicotine.

AB - People diagnosed with attention-deficit/hyperactivity disorder (ADHD) are at an increased risk to start smoking and have greater difficulty quitting. Nicotine, one of the principal addictive components of tobacco smoke, functioned as a conditioned stimulus (CS) for intermittent sucrose delivery in a Pavlovian drug discrimination task with rats. This study compared the ability of commonly prescribed ADHD medications (i.e., methylphenidate, atomoxetine, and bupropion) and additional dopamine reuptake inhibitors (i.e., cocaine and GBR 12909) to substitute for the CS effects of nicotine. Atomoxetine was also used to antagonize these CS effects. Rats acquired the discrimination as evidenced by increased dipper entries in nicotine (0.2 mg base/kg) sessions as compared with saline sessions. Nicotine generalization was dose dependent. Bupropion (10 and 20 mg/kg), methylphenidate (10 mg/kg), and cocaine (5 and 10 mg/kg) partially substituted for the 0.2 mg/kg nicotine CS. Atomoxetine did not substitute for the nicotine CS; however, atomoxetine (1 to 10 mg/kg) partially blocked nicotine's CS effects. These results suggest that atomoxetine, bupropion, and/or methylphenidate may be effective treatments for people diagnosed with ADHD and addicted to nicotine.

KW - dopamine

KW - drug discrimination

KW - interoceptive Pavlovian conditioning

KW - nicotinic acetylcholine receptors

KW - norepinephrine

UR - http://www.scopus.com/inward/record.url?scp=36048970084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36048970084&partnerID=8YFLogxK

U2 - 10.1037/1064-1297.15.5.501

DO - 10.1037/1064-1297.15.5.501

M3 - Article

C2 - 17924784

AN - SCOPUS:36048970084

VL - 15

SP - 501

EP - 509

JO - Experimental and Clinical Psychopharmacology

JF - Experimental and Clinical Psychopharmacology

SN - 1064-1297

IS - 5

ER -